Corporate action official notices
Barrier Discount Certificate on Nestlé, Novartis, Roche
CH1292089245
Barrier Discount Certificate on Richemont, Nestlé, Novartis, Roche, UBS
CH1292089252
Barrier Discount Certificate on Swiss Life, Swiss Re, Zurich Insurance
CH1292089260
Leonteq Securities AG - Zulassung zum Handel (Sponsored Segment)
LU0839027447
Beschrieb: Zulassung zum Handel. Kontakt: David Haab, Leonteq Securities AG, Europaallee 39, 8004 Zürich Telefon: +41 58 800 10 43 E-Mail: david.haab@leonteq.com Erster Handelstag: 12.05.2025 Datum der Veröffentlichung: 09.05.2025 Für die folgenden Instrumente wird die Zulassung zum Handel beantragt (Sponsored ETF): ISIN: LU0839027447 Name: Xtrackers Nikkei 225 UCITS ETF
Leonteq Securities AG - Early Redemptions
CH1390865991
Reason for the redemption: Issuer call Effective from: 12 May 2025 Publication as of: 13 May 2025
Leonteq Securities AG - Early Redemptions
CH1390863947, CH1390864119, CH1390864127
Reason for the redemption: Issuer call Effective from: 12 May 2025 Publication as of: 13 May 2025
Leonteq Securities AG - Zulassung zum Handel (Sponsored Segment)
US0994061002
Beschrieb: Zulassung zum Handel. Kontakt: David Haab, Leonteq Securities AG, Europaallee 39, 8004 Zürich Telefon: E-Mail: david.haab@leonteq.com Erster Handelstag: 12.05.2025 Datum der Veröffentlichung: 09.05.2025 Für die folgenden Instrumente wird die Zulassung zum Handel beantragt (Sponsored Share): ISIN: US0994061002 Name: Boot Barn Holdings Inc
Leonteq Securities AG: Listing of ETP on on Bountiful Enhancing the Common Good US NTR Index
CH1292092033
Official Notice – Listing of Exchange Traded Product on Bountiful Enhancing the Common Good US NTR Index Issuer: Leonteq Securities AG, Zurich, Switzerland Security description/name: Exchange Traded Product on Bountiful Enhancing the Common Good US NTR Index Swiss Security number: 129209203 ISIN: CH1292092033 BX Symbol: GODUS Issue Size: 1'000'000 Products Currency: USD Regulatory standard: The listing for the above-mentioned product has been applied for in accordance with the Additional Rules for the Listing of Exchange Traded Products on BX Swiss (Exchange Traded Product - ETP). Nature and brief description of the transaction: The Product is an Exchange Traded Product, which is issued as a SIX Triparty Collateral Management (“TCM”) Product and collateralized in accordance with the terms for TCM Products pursuant to the TCM Security Agreement and subject to compliance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Collateral Provider has entered into the TCM Security Agreement with SIX Repo AG as Collateral Agent and SIX SIS AG as depository and triparty collateral manager. The Collateral Provider will provide the collateral to secure the value of TCM Products, whereby such collateral can consist, among others, of the securities that are the direct or indirect underlying’s of the TCM Product but being in accordance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Product is issued under the Issuer’s base prospectus dated 18 June 2024 and the performance of the Product is linked to the Bountiful Enhancing the Common Good US NTR Index (the “Underlying”). The Product is a Swiss Uncertificated Security under Swiss law. During the whole term of this Product, further information with regards to the Underlying, the TCM Security Agreement and the relevant product documentation can be ordered free of charge from the Lead Manager. Trades in the above-mentioned Exchange Traded Product (ETP) will not be “CCP-eligible”. On the contrary to other products in the Exchange Traded Products segment on BX Swiss trades will be instructed for bilateral settlement (excluding the CCP). This Product is a derivative instrument according to Swiss law. It is categorized as an Exchange Traded Product and will be listed on the respective segment of BX Swiss. It does not qualify as unit of a collective investment scheme pursuant to article 7 et seqq. of the Swiss Federal Act on Collective Investment Schemes ("CISA") and is therefore neither registered nor supervised by the Swiss Financial Market Supervisory Authority FINMA. Investors do not benefit from the specific investor protection provided under the CISA. The First Exchange Trading Date of the Product is on 12.05.2025. In addition, the Product is listed on SIX Swiss Exchange AG; traded on SIX Swiss Exchange – Exchange Traded Products (ETPs). Lead Manager: Leonteq Securities AG, Zurich, Switzerland Paying Agent: Leonteq Securities AG, Zurich, Switzerland Calculation Agent: Leonteq Securities AG, Zurich, Switzerland Collateral Provider: Leonteq Securities AG, Zurich, Switzerland Authorized Participant: Leonteq Securities AG, Zurich, Switzerland
Leonteq Securities AG: Listing of ETP on on Swissquote Global Defense (CHF) Index
CH1292091993
Official Notice – Listing of Exchange Traded Product on Swissquote Global Defense (CHF) Index Issuer: Leonteq Securities AG, Zurich, Switzerland Security description/name: Exchange Traded Product on Swissquote Global Defense (CHF) Index Swiss Security number: 129209199 ISIN: CH1292091993 BX Symbol: DEFN Issue Size: 1'000'000 Products Currency: CHF Regulatory standard: The listing for the above-mentioned product has been applied for in accordance with the Additional Rules for the Listing of Exchange Traded Products on BX Swiss (Exchange Traded Product - ETP). Nature and brief description of the transaction: The Product is an Exchange Traded Product, which is issued as a SIX Triparty Collateral Management (“TCM”) Product and collateralized in accordance with the terms for TCM Products pursuant to the TCM Security Agreement and subject to compliance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Collateral Provider has entered into the TCM Security Agreement with SIX Repo AG as Collateral Agent and SIX SIS AG as depository and triparty collateral manager. The Collateral Provider will provide the collateral to secure the value of TCM Products, whereby such collateral can consist, among others, of the securities that are the direct or indirect underlying’s of the TCM Product but being in accordance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Product is issued under the Issuer’s base prospectus dated 18 June 2024 and the performance of the Product is linked to the Swissquote Global Defense (CHF) Index (the “Underlying”). The Product is a Swiss Uncertificated Security under Swiss law. During the whole term of this Product, further information with regards to the Underlying, the TCM Security Agreement and the relevant product documentation can be ordered free of charge from the Lead Manager. Trades in the above-mentioned Exchange Traded Product (ETP) will not be “CCP-eligible”. On the contrary to other products in the Exchange Traded Products segment on BX Swiss trades will be instructed for bilateral settlement (excluding the CCP). This Product is a derivative instrument according to Swiss law. It is categorized as an Exchange Traded Product and will be listed on the respective segment of SIX Swiss Exchange. It is categorized as an Exchange Traded Product and will be listed on the respective segment of BX Swiss. It does not qualify as unit of a collective investment scheme pursuant to article 7 et seqq. of the Swiss Federal Act on Collective Investment Schemes ("CISA") and is therefore neither registered nor supervised by the Swiss Financial Market Supervisory Authority FINMA. Investors do not benefit from the specific investor protection provided under the CISA. The First Exchange Trading Date of the Product is on 12.05.2025. In addition, the Product is listed on SIX Swiss Exchange AG; traded on SIX Swiss Exchange – Exchange Traded Products (ETPs). Lead Manager: Leonteq Securities AG, Zurich, Switzerland Paying Agent: Leonteq Securities AG, Zurich, Switzerland Calculation Agent: Leonteq Securities AG, Zurich, Switzerland Collateral Provider: Leonteq Securities AG, Zurich, Switzerland Authorized Participant: Leonteq Securities AG, Zurich, Switzerland
Strike/Barrier Adjustment SG - 12.05.2025
The following strike/barrier adjustments were made:
12.60% p.a. Barrier Reverse Convertible on Boeing
CH1390862105
14.00% p.a. Barrier Reverse Convertible on Albemarle
CH1261618065
18.00% p.a. Barrier Reverse Convertible on Albemarle
CH1261618081
Aryzta AG
CH0043238366
Barrier Discount Certificate on Roche
CH1325421530
Barrier Discount Certificate on Roche
CH1325421563
Barrier Discount Certificate on Roche
CH1325421589
Barrier Discount Certificate on Roche
CH1325421696
Barrier Discount Certificate on Roche
CH1325421704
De Grey Mining Ltd
AU000000DEG6
Lions Gate Entertainment Corp Class A
CA5359194019
Lions Gate Entertainment Corp Class B
CA5359195008
Short Mini Future auf Geberit AG
CH1418933359
8.64% p.a. Multi Reverse Convertible on Novartis, Roche, Strategy, Swissquote, Zurich Insurance
CH1438094117
Bank Julius Baer & Co. Ltd. - Anpassungen von Produkten mit Basiswert Barrick Gold Corp.
CH1430260716,CH1405809026
Notice to Investors of products on Barrick Gold Corp (ISIN CA0679011084; GOLD US): Effective Date: 09.05.2025 Publication Date: 09.05.2025 The conditions of the below mentioned products have changed as follows: Id Number Change ISIN CH1430260716 Valor 143026071 ISIN old CA0679011084 Ticker old GOLD US ISIN new CA06849F1080 Ticker new B US ISIN CH1405809026 Valor 140580902 ISIN old CA0679011084 Ticker old GOLD US ISIN new CA06849F1080 Ticker new B US